Select Medical Holdings (SEM) Net Margin (2018 - 2026)

Select Medical Holdings has disclosed Net Margin across 9 years of filings, most recently posting 4.49% for Q1 2026.

• In Q1 2026, Net Margin rose 2796.0% year-over-year to 4.49%; the TTM figure through Mar 2026 stood at 16.18% (down 634.0% YoY), while the FY2025 annual figure was 5.71%, down 268.0% from the prior year.
• Net Margin climbed to 4.49% in Q1 2026, from 22.29% in the prior quarter.
• Over the last five years, Net Margin for SEM reached as high as 263.4% in Q4 2022 and fell as low as 24.17% in Q2 2025.
• The 5-year median for Net Margin is 3.5% (2022), against an average of 9.95%.
• Annual changes were most pronounced in 2022 — Net Margin soared 27299 bps — and 2023, when it tumbled 28211 bps.
• A 5-year view of Net Margin shows it stood at 263.4% in 2022, then plunged by 107 bps to 18.71% in 2023, then fell by 19 bps to 22.2% in 2024, then fell by 0 bps to 22.29% in 2025, then surged by 120 bps to 4.49% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 4.49%, 22.29%, and 23.61% for Q1 2026, Q4 2025, and Q3 2025 respectively.